Ge Healthcare Technologies Inc. (GEHC) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Ge Healthcare Technologies Inc. (GEHC) stock forecast summary
Our AI scores Ge Healthcare Technologies Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Ge Healthcare Technologies Inc. is a large-cap company with a market capitalization of $37.25B.
For GEHC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 45.0%, measured on 321 forecast dates between 2023-04-28 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 23.0%, measured on 364 forecast dates between 2023-04-28 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, GEHC included.
GEHC price chart and AI forecast
How GEHC ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Ge Healthcare Technologies Inc. (GEHC) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the X-Ray Apparatus & Tubes & Related Irradiation Apparatus peers listed below that report each metric.
Valuation & Market
| Metric | GEHC | Rank |
|---|---|---|
| Market Cap | $37.25B | – |
| P/E Ratio | 17.45x | – |
| P/B Ratio | 3.21x | – |
| Dividend Yield | 0.17% | – |
| EPS | $4.72 | – |
| Book Value/Share | $25.69 | – |
| Revenue/Share | $47.85 | – |
| FCF/Share | $4.18 | – |
Profitability & Margins
| Metric | GEHC | Rank |
|---|---|---|
| ROE | 18.5% | – |
| ROA | 5.6% | – |
| ROIC | 9.8% | – |
| Gross Margin | 39.9% | – |
| Operating Margin | 13.3% | – |
| Net Margin | 9.9% | – |
| EBT Margin | 12.8% | – |
| Tax Rate | 20.2% | – |
Financial Health
| Metric | GEHC | Rank |
|---|---|---|
| Current Ratio | 1.30x | – |
| Quick Ratio | 1.01x | – |
| D/E Ratio | 2.28x | – |
| Financial Leverage | 3.30x | – |
| Interest Coverage | 9.6x | – |
| Working Capital | $2.68B | – |
Cash Flow
| Metric | GEHC | Rank |
|---|---|---|
| Operating Cash Flow | $2.42B | – |
| Free Cash Flow | $1.89B | – |
| Capital Spending | -$526M | – |
| OCF Growth YoY | 30.5% | – |
| FCF Growth YoY | 7.7% | – |
| FCF/Sales | 8.7% | – |
| CapEx/Sales | 2.4% | – |
Operational Efficiency
| Metric | GEHC | Rank |
|---|---|---|
| Asset Turnover | 0.56x | – |
| Receivables Turnover | 6.2x | – |
| Fixed Assets Turnover | 7.6x | – |
| Days Sales Outstanding | 59 days | – |
Income Statement
| Metric | GEHC | Rank |
|---|---|---|
| Total Revenue | $21.64B | – |
| Operating Income | $2.89B | – |
| Net Income | $2.15B | – |
| R&D Expense | $1.31B | – |
| SG&A Expense | $4.45B | – |
Dividend & Shareholder Information
| Metric | GEHC | Rank |
|---|---|---|
| Dividends Per Share | $0.14 | – |
| Payout Ratio | 3.0% | – |
| Shares Outstanding | 452M | – |
| Net Income Growth | -2.9% | – |
| EPS Growth | -16.6% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $11.49B | 30.0% of assets |
| Cash & Short-term Investments | $2.83B | 7.4% of assets |
| Accounts Receivable | $3.51B | 9.1% of assets |
| Inventory | $2.63B | 6.8% of assets |
| Total Liabilities | $26.51B | 69.1% of assets |
| Short-term Debt | $5.50B | 14.3% of assets |
GEHC quarterly financials and insider trading
Ge Healthcare Technologies Inc. (GEHC) industry peers
Companies classified under the same SEC industry code as Ge Healthcare Technologies Inc. (X-Ray Apparatus & Tubes & Related Irradiation Apparatus): 3 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere GEHC sits on the market map
Ge Healthcare Technologies Inc. (GEHC) stock news
Loading...
Ge Healthcare Technologies Inc. (GEHC) stock forecast FAQ
What is the Ge Healthcare Technologies Inc. (GEHC) stock forecast?
Our AI scores Ge Healthcare Technologies Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Ge Healthcare Technologies Inc. stock predictions?
For GEHC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 45.0%, measured on 321 forecast dates between 2023-04-28 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 23.0%, measured on 364 forecast dates between 2023-04-28 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Ge Healthcare Technologies Inc. forecasts updated?
Ge Healthcare Technologies Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Ge Healthcare Technologies Inc.'s industry peers?
3 issuers in our coverage, GEHC included, share the SEC industry code X-Ray Apparatus & Tubes & Related Irradiation Apparatus. The largest are: Koninklijke Philips Nv (PHG), Butterfly Network, Inc. (BFLY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.